Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Allergies · Early Parkinson Disease

Advanced Accelerator Applications

Advanced Accelerator Applications trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON HQ
590 Employees
EMA registrant Type
Company details
Status
Public
HQ
20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
Employees
590
Programs
12
Drugs
25
Patents
25
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Advanced Accelerator Applications clinical trials

Registry index of 12 ClinicalTrials.gov studies linked to Advanced Accelerator Applications programs — each row shows trial ID, program name, phase, status, and indication.

Advanced Accelerator Applications trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Advanced Accelerator Applications.

  1. ABX-CT-302EU/EAGLE-i — Phase 3

    Clinical update

  2. ODYSSEY — Phase 1

    Clinical update

  3. CAAA601A32201 — Phase 2

    Clinical update

  4. CAAA601A22301 — Phase 3

    Clinical update

  5. APISLIT-DD-D-2025-01 — Phase 2

    Clinical update

  6. API-EAL-2024-01 — Phase 2

    Clinical update

  7. API-EAD-2024-01 — Phase 2

    Clinical update

  8. Vodobatinib (K0706) capsules — Phase 2

    Clinical update

Trial registry

12 studies
  6. 2024-518813-24-00

    ODYSSEY

    Phase 1 active other

    Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes, Ineligible for Intensiveor New Generation Targeted Therapy

    CTIS ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.